Compliance Officers To OIG: Give Us More Flexibility In Implementing Corporate Integrity Agreements
Executive Summary
A government-industry pharmaceutical compliance roundtable gives positive marks to board certification but calls for revisions to independent review organization practices and internal monitoring requirements.